Vertudazo, Anita .

HRN: 51-89-99  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/18/2022
CEFTAZIDIME 1GM (VIAL)
09/18/2022
09/23/2022
IV
2g
Q8h
Ascending Cholangitis, Cholelithiasis
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Guideline Not Available

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: